Chinook Therapeutics Inc Cvr (ADRO)
R&D Expense Growth
-16.89%
Quarterly · Period ending:
ADRO R&D Expense Growth
Latest reported-16.89%period ending
Latest reported-16.89%period ending
ADRO Quarterly R&D Growth (QoQ) (0.00% → -16.89%)
Latest values, visible window
High-resolution chart · PNG
ADRO r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -16.8887% | |
| -29.8206% | |
| 4.6203% | |
| -2.4565% | |
| -8.0943% | |
| -13.5893% | |
| 10.884% | |
| -5.6867% | |
| -3.8363% | |
| -3.5175% | |
| -12.1738% | |
| -6.2812% | |
| 14.0578% | |
| 4.2193% | |
| -1.3948% | |
| 9.5401% | |
| -29.1496% | |
| 28.4561% | |
| -7.6356% | |
| 91.7972% | |
| -12.7097% | |
| 27.1182% | |
| 0% | |
| 0% | |
| 8.4212% | |
| 14.2525% | |
| 0% |